Kestra Advisory Services’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$264K Sell
4,202
-4,534
-52% -$316K ﹤0.01% 2740
2025
Q4
$580K Buy
8,736
+1,430
+20% +$92.5K ﹤0.01% 2037
2025
Q3
$492K Sell
7,306
-2,033
-22% -$161K ﹤0.01% 2083
2025
Q2
$815K Sell
9,339
-492
-5% -$38.6K ﹤0.01% 1622
2025
Q1
$671K Sell
9,831
-9,885
-50% -$807K ﹤0.01% 1633
2024
Q4
$1.53M Buy
19,716
+1,304
+7% +$96.5K 0.01% 1146
2024
Q3
$1.23M Buy
18,412
+4,126
+29% +$339K 0.01% 1210
2024
Q2
$1.62M Sell
14,286
-128
-0.9% -$16.2K 0.01% 1068
2024
Q1
$2M Buy
14,414
+172
+1% +$21.6K 0.01% 880
2023
Q4
$1.77M Buy
14,242
+407
+3% +$41.6K 0.01% 849
2023
Q3
$1.29M Sell
13,835
-1,785
-11% -$201K 0.01% 875
2023
Q2
$2.01M Buy
15,620
+1,866
+14% +$226K 0.02% 670
2023
Q1
$1.6M Sell
13,754
-14,213
-51% -$1.59M 0.02% 733
2022
Q4
$3.17M Buy
27,967
+4,187
+18% +$460K 0.03% 573
2022
Q3
$1.92M Sell
23,780
-7,053
-23% -$597K 0.02% 680
2022
Q2
$2.3M Buy
30,833
+15,177
+97% +$1.39M 0.02% 623
2022
Q1
$2M Buy
15,656
+6,360
+68% +$696K 0.02% 675
2021
Q4
$1.25M Sell
9,296
-704
-7% -$101K 0.01% 884
2021
Q3
$1.37M Buy
10,000
+1,492
+18% +$188K 0.01% 861
2021
Q2
$908K Buy
8,508
+1,284
+18% +$123K 0.01% 996
2021
Q1
$649K Buy
7,224
+568
+9% +$53.3K 0.01% 1070
2020
Q4
$604K Buy
6,656
+6,436
+2,925% +$575K 0.01% 1110
2020
Q3
$1.46M Buy
+220
New +$23K 0.03% 508

Other funds holding DXCM

Kestra Advisory Services's DXCM Position: Q1 2026 in Review

Kestra Advisory Services reduced its DexCom (DXCM) stake by 52% in Q1 2026, selling an estimated $316K and leaving 4,202 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #2740.

Kestra Advisory Services first reported a position in DXCM in Q3 2020 and has held it in 23 quarters since. The position peaked at $3.17M in Q4 2022. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Kestra Advisory Services held 4,202 shares of DexCom worth $264K as of Q1 2026.
  • Kestra Advisory Services sold 4,534 DexCom shares in Q1 2026, an estimated $316K.
  • DexCom made up ﹤0.01% of Kestra Advisory Services's portfolio in Q1 2026, its #2740 holding.
  • Kestra Advisory Services first reported a position in DexCom in Q3 2020 and has held it in 23 quarters since.
  • Kestra Advisory Services's DexCom position peaked at $3.17M in Q4 2022.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Kestra Advisory Services's 13F filing for Q1 2026, filed 30 Apr 2026.